AAAAAA

   
Results: 1-11 |
Results: 11
A cell-based model of hemostasis
Authors: Hoffman, M Monroe, DM
Citation: M. Hoffman et Dm. Monroe, A cell-based model of hemostasis, THROMB HAEM, 85(6), 2001, pp. 958-965
The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis
Authors: Hoffman, M Monroe, DM
Citation: M. Hoffman et Dm. Monroe, The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis, SEM HEMATOL, 38(4), 2001, pp. 6-9
High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system
Authors: Kjalke, M Ezban, M Monroe, DM Hoffman, M Roberts, HR Hedner, U
Citation: M. Kjalke et al., High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system, BR J HAEM, 114(1), 2001, pp. 114-120
The effect of factor X level on thrombin generation and the procoagulant effect of activated factor VII in a cell-based model of coagulation
Authors: Allen, GA Monroe, DM Roberts, HR Hoffman, M
Citation: Ga. Allen et al., The effect of factor X level on thrombin generation and the procoagulant effect of activated factor VII in a cell-based model of coagulation, BL COAG FIB, 11, 2000, pp. S3-S7
Coagulation factor XI is a contaminant in intravenous immunoglobulin preparations
Authors: Wolberg, AS Kon, RH Monroe, DM Hoffman, M
Citation: As. Wolberg et al., Coagulation factor XI is a contaminant in intravenous immunoglobulin preparations, AM J HEMAT, 65(1), 2000, pp. 30-34
Links between the immune and coagulation systems: How do "Antiphospholipidantibodies" cause thrombosis?
Authors: Hoffman, M Monroe, DM Roubey, RAS
Citation: M. Hoffman et al., Links between the immune and coagulation systems: How do "Antiphospholipidantibodies" cause thrombosis?, IMMUNOL RES, 22(2-3), 2000, pp. 191-197
The factor VII-Platelet interplay: Effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia
Authors: Monroe, DM Hoffman, M Allen, GA Roberts, HR
Citation: Dm. Monroe et al., The factor VII-Platelet interplay: Effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia, SEM THROMB, 26(4), 2000, pp. 373-377
Deencryption of cellular tissue factor is independent of its cytoplasmic domain
Authors: Wolberg, AS Kon, RH Monroe, DM Ezban, M Roberts, HR Hoffman, M
Citation: As. Wolberg et al., Deencryption of cellular tissue factor is independent of its cytoplasmic domain, BIOC BIOP R, 272(2), 2000, pp. 332-336
Thrombin activates factor XI on activated platelets in the absence of factor XII
Authors: Oliver, JA Monroe, DM Roberts, HR Hoffman, M
Citation: Ja. Oliver et al., Thrombin activates factor XI on activated platelets in the absence of factor XII, ART THROM V, 19(1), 1999, pp. 170-177
Tissue factor de-encryption: ionophore treatment induces changes in tissuefactor activity by phosphatidylserine-dependent and -independent mechanisms
Authors: Wolberg, AS Monroe, DM Roberts, HR Hoffman, MR
Citation: As. Wolberg et al., Tissue factor de-encryption: ionophore treatment induces changes in tissuefactor activity by phosphatidylserine-dependent and -independent mechanisms, BL COAG FIB, 10(4), 1999, pp. 201-210
TFPI beta, a second product from the mouse tissue factor pathway inhibitor(TFPI) gene
Authors: Chang, JY Monroe, DM Oliver, JA Roberts, HR
Citation: Jy. Chang et al., TFPI beta, a second product from the mouse tissue factor pathway inhibitor(TFPI) gene, THROMB HAEM, 81(1), 1999, pp. 45-49
Risultati: 1-11 |